The boss of the drugs giant behind Ozempic has quit after falling behind in the global race to develop weight-loss medication ...

In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro ...

The millions of people living with obesity need novel treatment options that are safe, effective and avoid the high costs and ...

Hollywood celebrities using popular weight loss drug Ozempic to shred those unwanted pounds are now facing an unexpected new ...

Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday ...

"The changes are made in light of the recent market challenges Novo Nordisk has been facing, and the development of the ...

Costly drugs: The drugs prescribed to fight obesity have been driving up the cost of Medi-Cal, the state program that ...

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

Lars Fruergaard Jørgensen, who has led the pharmaceutical giant since 2017, joined the firm in 1991. View on euronews ...

Popular weight loss drugs Ozempic and Wegovy would no longer be covered by Medi-Cal under a proposal unveiled by Gov. The costly drugs prescribed to fight obesity have been driving up the cost of Medi ...

WGN’s Dina Bair has the latest on new medical information, including: Study: Mounjaro helped people achieve more weight loss ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...